Cost-effectiveness of the anti-vascular endothelial growth factor intravitreal injection and panretinal photocoagulation for patients with proliferative diabetic retinopathy in South Korea

被引：0
|
作者：
Hyeon-Jeong Lee
Songhee Cho
Jungeun Park
Yan Jin
Hyung Min Kim
Donghyun Jee
机构：
[1] National Evidence-based Healthcare Collaborating Agency,Division of Healthcare Technology Assessment Research
[2] National Evidence-based Healthcare Collaborating Agency,Patient
[3] Nanjing University of Chinese Medicine,Centered Clinical Research Coordinating Center
[4] Kai Health,Department of Rehabilitation, College of Acupuncture and Moxibustion and Massage Health Preservation and Rehabilitation
[5] St. Vincent’s Hospital,Artificial intelligence
[6] The College of Medicine,Department of Ophthalmology and Visual Science
[7] Catholic University of Korea,undefined
来源：
BMC Health Services Research | / 23卷
关键词：
Anti-VEGF injection; Cost-effectiveness analysis; Panretinal Photocoagulation; Proliferative diabetic retinopathy; South Korea;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] COMPLIANCE AND ADHERENCE OF PATIENTS WITH DIABETIC MACULAR EDEMA TO INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN DAILY PRACTICE
    Weiss, Maximilian
    Sim, Dawn A.
    Herold, Tina
    Schumann, Ricarda G.
    Liegl, Raffael
    Kern, Christoph
    Kreutzer, Thomas
    Schiefelbein, Johannes
    Rottmann, Miriam
    Priglinger, Siegfried
    Kortuem, Karsten Ulrich
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (12): : 2293 - 2300
  • [32] Evaluation Of The Timing Of Intravitreal Bevacizumab Injection As Adjuvant Therapy To Panretinal Photocoagulation In Patients With Diabetic Macular Edema Secondary To Diabetic Retinopathy
    Kartasasmita, Arief
    Harley, Ohisa
    CLINICAL OPHTHALMOLOGY, 2019, 13 : 1921 - 1926
  • [33] Vascular endothelial growth factor inhibition and proliferative diabetic retinopathy, a changing treatment paradigm?
    Wu, Lihteh
    Acon, Dhariana
    Wu, Andres
    Wu, Max
    TAIWAN JOURNAL OF OPHTHALMOLOGY, 2019, 9 (04) : 216 - 223
  • [34] Comment on: A Caveat About Financial Incentives for Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy
    Gosala, Seshubabu
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2023, 250 : 190 - 191
  • [35] Anti-Vascular Endothelial Growth Factor Therapy for Complications of Diabetic Retinopathy-From Treatment to Prevention?
    Tan, Tien-En
    Sivaprasad, Sobha
    Wong, Tien Yin
    JAMA OPHTHALMOLOGY, 2023, 141 (03) : 223 - 225
  • [36] Vascular endothelial growth factor levels in vitreous and serum of patients with either proliferative diabetic retinopathy or proliferative vitreoretinopathy
    Sydorova, M
    Lee, MS
    OPHTHALMIC RESEARCH, 2005, 37 (04) : 188 - 190
  • [37] VITREOUS AND PLASMA CONCENTRATIONS OF APELIN AND VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER INTRAVITREAL BEVACIZUMAB IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY
    Qian, Jing
    Lu, Qiang
    Tao, Yong
    Jiang, Yan-Rong
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (01): : 161 - 168
  • [38] Anti-Vascular Endothelial Growth Factor Therapy as an Adjunct to Diabetic Vitrectomy
    Karimov, Mushfig
    Akhundova, Lala
    OPEN OPHTHALMOLOGY JOURNAL, 2021, 15 : 137 - 143
  • [39] Vitreous Vascular Endothelial Growth Factor Concentrations in Proliferative Diabetic Retinopathy versus Proliferative Vitreoretinopathy
    Citirik, Mehmet
    Kabatas, Emrah Utku
    Batman, Cosar
    Akin, Kadir Okhan
    Kabatas, Naciye
    OPHTHALMIC RESEARCH, 2012, 47 (01) : 7 - 12
  • [40] Monitoring intraocular proangiogenic and profibrotic cytokines within 7 days after adjunctive anti-vascular endothelial growth factor therapy for proliferative diabetic retinopathy
    Hu, Zizhong
    Cao, Xin
    Chen, Lu
    Su, Yun
    Ji, Jiangdong
    Yuan, Songtao
    Fransisca, Silvia
    Mugisha, Aime
    Zou, Wenjun
    Xie, Ping
    Liu, Qinghuai
    ACTA OPHTHALMOLOGICA, 2022, 100 (03) : E726 - E736
12345